Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Joint research at Ortho-McNeil and Cor leads to new peptoid/peptidomimetic PAR-1 antagonists

Feb. 16, 2001

Takeda claims potent new factor Xa inhibitors

Feb. 15, 2001

Thrombin inhibitors with high selectivity designed at ADIR

Feb. 14, 2001

Avigen/Bayer hemophilia B collaboration becomes effective

Feb. 13, 2001

Genzyme Transgenics updates rhATIII development status

Feb. 13, 2001

Sanofi Synthelabo/Organon pentasaccharide can be reversed only by Neutralase

Feb. 13, 2001

Peptide inhibitors of alphavbeta6 integrin disclosed by Merck KGaA

Feb. 8, 2001

Novel anticoagulants synthesized and tested at Aventis

Jan. 30, 2001

Merck discloses two series of thrombin inhibitors in recent patents

Jan. 29, 2001

CI-1028: a direct thrombin inhibitor with oral antithrombotic efficacy

Jan. 23, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...